New Drug Prevents Migraines Before They Start

Wochit - May 18, 2018
The FDA approved a new migraine drug on Thursday.

Aimovig, known generically as erenumab, is the first drug shown to stop migraine headaches before they start.

The drug would be approved for patients who have tried other drugs and found no relief.

In studies, it did not entirely prevent migraines, but reduced their frequency.

FDA's approval means the drug may soon be available under prescription. It should also be paid for by health insurance. The drug's maker, Amgen, said U.S.

list price is for the once monthly self-injection treatment will be $575 per month or $6,900 annually..


Recent related news

Elite Pharmaceuticals Inc (OTCBB:ELTP), a pharmaceutical group that develops abuse-deterrent opioids and niche generic drugs, has unveiled positive top-line...
6 days ago • Proactive Investors

Stemline Therapeutics Inc (NASDAQ:STML) announced Monday that the US Food and Drug Administration gave the green light to the filing of its biologics license...
1 week ago • Proactive Investors

You might like